Evidence supporting the use of: DIM (diindolylmethane)
For the health condition: Breast Lumps

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Diindolylmethane (DIM) is a compound derived from the digestion of indole-3-carbinol, found in cruciferous vegetables such as broccoli and Brussels sprouts. DIM is used primarily for its effects on estrogen metabolism; it is believed to promote the formation of beneficial estrogen metabolites while reducing the formation of potentially harmful ones. This biochemical property has led to its popular use in supporting breast health, including conditions like breast lumps, which are often related to benign fibrocystic breast changes or hormonal imbalances.

There is some scientific evidence from laboratory and animal studies suggesting that DIM can influence estrogen metabolism in a way that may reduce the risk of estrogen-sensitive conditions. Limited small human studies have shown that DIM supplementation alters urinary estrogen metabolite ratios in a potentially favorable direction. However, when it comes specifically to the treatment or prevention of benign breast lumps or fibrocystic breast disease, the human clinical evidence is quite limited. Most supporting data are indirect—focusing on estrogen metabolism rather than direct clinical outcomes related to breast lumps.

Thus, while the rationale for using DIM in this context is grounded in plausible biological mechanisms and some early research, there is not enough robust clinical evidence to strongly support its efficacy for treating or preventing breast lumps. Larger and more rigorous human studies are needed. The current evidence level is therefore rated as 2 out of 5, reflecting preliminary but incomplete scientific validation.

More about DIM (diindolylmethane)
More about Breast Lumps

Products containing DIM (diindolylmethane)